Compare Humana Inc (HUM) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Prospect Capital Corporation — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Prospect Capital Corporation trades at $1.72 (market cap $974.22M). The key difference: Humana Inc is far larger — about 47.7× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.01%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Prospect Capital Corporation for 78 Days on average.
| HUM | PSEC | |
|---|---|---|
Market Cap | $46.49B | $974.22M |
Volume | 2,567,704 | 5,779,996 |
Sector | Health | Financials |
52-Week High | $409.85 | $3.05 |
52-Week Low | $163.67 | $1.82 |
Typical Hold Time | 51 Days | 78 Days |
Enterprise Value | $53.84B | $2.73B |
Dividend Yield | 0.91% | 23.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
PSEC trades at $1.82, down 1.09% today, with a bearish technical outlook from moving averages. The company shows mixed fundamentals with a low P/B of 0.33 but concerning revenue volatility, including a -$407M revenue in 2025. Recent quarterly EPS has consistently beaten expectations, and the company maintains regular dividend distributions. Analyst sentiment is cautious with 55% hold ratings, while technical indicators show oversold conditions with RSI below 10.
PSEC presents a high-risk opportunity with a discounted valuation and strong dividend yield, but faces significant challenges from volatile revenue performance and negative cash flow. The stock's current technical weakness and mixed analyst consensus suggest cautious approach required despite attractive yield characteristics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
